Biopharma Expertise from F1000Prime
Jinfo Blog
28th February 2014
Abstract
The best articles in biological and medical research are handpicked by experts to appear in F1000Prime's database. Yulia Aspinall highlights two of the key features which help to generate more opportunities for innovation in biopharmaceutical research and development.
Item
It's a well known fact that internal knowledge is the biggest asset of any company or corporation.
Do you know any online resource which captures specialists' knowledge and makes it available to the wide audience of researchers? I do, it's called Faculty of 1000.
Faculty of 1000 is a publisher which provides access to the assessments of published articles chosen and written by the leading experts in biology and medicine, via its F1000Prime service.
Dedicated to Life Scientists & Clinicians
The company was founded by publishing entrepreneur Vitek Tracz and is part of the Science Navigation Group. Faculty of 1000 provides three specific offerings intended to support and inform the work of life scientists and clinicians:
- F1000Prime, which provides a database of recommendations of the best articles in medical and biological research
- F1000Research, an open access, open peer-reviewed journal
- F1000Posters, an open access resource for slide presentations and posters in medicine and biology.
Articles Recommended by Experts
F1000Prime was launched in 2002 as a collaboration initially of 1,000 international faculty members.
That number continues to grow and the faculty now consists of nearly 6,000 experts worldwide, together with designated associates. Faculty Members are organised into over 40 Faculties (subjects), which are further subdivided into over 300 Sections.
Heads of Faculty are world-renowned scientists and clinicians who are nominated and elected by discussion with a large group of their peers.
Members identify and recommend important articles in biology and medical research publications, and these recommendations join a fully searchable database containing more than 150,000 records. Articles are rated and expert commentaries explain their importance.
Peer-Reviewed Reports
A unique aspect of the database is F1000Prime Reports.
This is an open access journal that expands on the recommended literature coverage of F1000Prime by publishing peer-reviewed reports to provide context on emerging themes in biology and medicine.
F1000Prime Section Heads ensure coverage of the latest advances by selecting topics and nominating authors. The journal is indexed and/or abstracted by PubMed, PubMed Central, Scopus, Embase, Global Health and CAB Abstracts.
Discussions via Journal Club
In addition, a sharing tool, called F1000Journal Clubs was recently launched.
This is a tool for users to create, organise, manage and share their journal club meetings with F1000Prime. Users can use F1000Journal Clubs to choose an article to discuss with their peers and share the outcome by setting up their journal club with the tool.
Generate More Opportunities for Innovation
Overall, the value of F1000Prime content at the first glance could be underestimated.
The content is not just a collection of interesting articles but the top industry experts' knowledge repository. Access to this repository gives researchers the opportunity to learn, use and monitor experts' knowledge for their own benefits and for the benefit of the organisation.
Tools such as article nomination, ability to comment and share the existing content, and the journal club are actually knowledge exchange tools.
So, if you are a researcher, try F1000Prime, exchange your knowledge with the top industry experts' knowledge and generate more opportunities for innovation in biopharmaceutical research and development.
Editor's Note:
F1000Prime has a host of interesting features. FreePint Subscribers can log in now to read the Mini Review: F1000Prime.
- Blog post title: Biopharma Expertise from F1000Prime
- Link to this page
- View printable version
- Merger Mania in Biopharma: Will Information Professionals be Victims, Witnesses or Winners?
Friday, 20th December 2013 - Mini Review: IngentaConnect
Friday, 13th December 2013 - Collecting Human Competitive Intelligence: Challenges and Solutions
Thursday, 26th September 2013 - Mini Review: Best Practices LLC
Tuesday, 17th September 2013 - PharmaTell: A One Stop Shop for Biopharmaceutical Competitive intelligence?
Thursday, 18th July 2013 - ProQuest Dialog: Nearly Ready for Prime Time
Tuesday, 18th June 2013 - Searching Biomedical Literature: An Alternative Way
Thursday, 2nd May 2013
- Biopharma: Translation Tools Come of Age
Tuesday, 21st January 2014
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024